Droplet IV

About

Droplet IV is a medical device company based in Copenhagen, Denmark, founded in 2022. The company specializes in automated solutions for flushing intravenous (IV) lines, aiming to enhance patient safety and nursing efficiency while reducing medication waste. Their flagship product is an automatic IV-line flushing device designed to ensure full medication delivery by eliminating manual flushing after small-volume infusions. The device addresses a significant challenge in IV therapy, where over 20% of medication can be lost in lines. By automating this process, Droplet IV helps prevent dosing errors, saves nursing time, and minimizes waste. The company is preparing for regulatory approval and plans to launch its product in the EU and US markets by 2026. With over $5 million in funding, including contributions from healthcare investors and grants, Droplet IV is positioned to make a meaningful impact in the $12 billion IV therapy market.